# Ceribell, Inc.: filings CBLL · Nasdaq · CIK 1861107 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/cbll.md) · [Financials](/companies/cbll/financials.md) · [Filings](/companies/cbll/filings.md) · [Insiders](/companies/cbll/insiders.md) ## Reports and events: 39 filings Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 111, 144 83, 8-K 24, 3 16, SCHEDULE 13G/A 8, 10-Q 6, CORRESP 6, SCHEDULE 13G 6, 4/A 4, UPLOAD 4, DEFA14A 3, S-1/A 3, S-8 3, 10-K 2, ARS 2, DEF 14A 2, EFFECT 2, SEC STAFF LETTER 2, 3/A 1, 424B4 1, 8-A12B 1, CERT 1, D 1, D/A 1, DRS 1, DRS/A 1, DRSLTR 1, FWP 1, S-1 1, S-3 1, SC 13D 1, SC 13G 1). | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-08-10 | 20:50 ET | [10-Q](/filings/0001193125-26-342574.md) | Quarterly report, period 2026-06-30 | 0001193125-26-342574 | | 2026-08-10 | 20:27 ET | [8-K](/filings/0001193125-26-342463.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-342463 | | 2026-07-30 | 23:00 ET | [8-K](/filings/0001193125-26-324378.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-324378 | | 2026-06-02 | 20:19 ET | [8-K](/filings/0001193125-26-253558.md) | 5.07 Shareholder vote results | 0001193125-26-253558 | | 2026-05-11 | 20:49 ET | [10-Q](/filings/0001193125-26-217008.md) | Quarterly report, period 2026-03-31 | 0001193125-26-217008 | | 2026-05-11 | 20:16 ET | [8-K](/filings/0001193125-26-216821.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-216821 | | 2026-04-20 | 16:18 ET | [DEF 14A](/filings/0001193125-26-163290.md) | Proxy statement, period 2026-06-02 | 0001193125-26-163290 | | 2026-02-24 | 21:36 ET | [10-K](/filings/0001193125-26-067238.md) | Annual report, period 2025-12-31 | 0001193125-26-067238 | | 2026-02-24 | 21:23 ET | [8-K](/filings/0001193125-26-067136.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-067136 | | 2026-01-05 | 15:53 ET | [8-K](/filings/0001193125-26-001800.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-001800 | | 2026-01-02 | 21:45 ET | [8-K](/filings/0001193125-26-000994.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-000994 | | 2025-12-12 | 18:13 ET | [8-K](/filings/0001193125-25-317295.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-25-317295 | | 2025-12-09 | 14:16 ET | [8-K](/filings/0001193125-25-312035.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-312035 | | 2025-11-24 | 13:16 ET | [8-K](/filings/0001193125-25-292140.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-292140 | | 2025-11-04 | 21:46 ET | [10-Q](/filings/0001193125-25-264882.md) | Quarterly report, period 2025-09-30 | 0001193125-25-264882 | | 2025-11-04 | 21:11 ET | [8-K](/filings/0001193125-25-264699.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-264699 | | 2025-09-24 | 16:58 ET | [8-K](/filings/0001193125-25-214813.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-25-214813 | | 2025-09-22 | 13:14 ET | [8-K](/filings/0001193125-25-210195.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-210195 | | 2025-08-05 | 20:40 ET | [10-Q](/filings/0000950170-25-103142.md) | Quarterly report, period 2025-06-30 | 0000950170-25-103142 | | 2025-08-05 | 20:14 ET | [8-K](/filings/0000950170-25-103052.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-103052 | | 2025-07-07 | 21:21 ET | [8-K](/filings/0000950170-25-094303.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-094303 | | 2025-06-20 | 16:45 ET | [8-K](/filings/0000950170-25-088309.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000950170-25-088309 | | 2025-06-12 | 15:50 ET | [8-K](/filings/0000950170-25-085227.md) | 5.07 Shareholder vote results | 0000950170-25-085227 | | 2025-05-08 | 20:36 ET | [10-Q](/filings/0000950170-25-067097.md) | Quarterly report, period 2025-03-31 | 0000950170-25-067097 | | 2025-05-08 | 20:13 ET | [8-K](/filings/0000950170-25-066974.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-066974 | | 2025-04-30 | 14:45 ET | [DEF 14A](/filings/0000950170-25-060705.md) | Proxy statement, period 2025-04-29 | 0000950170-25-060705 | | 2025-04-11 | 12:00 ET | [8-K](/filings/0000950170-25-053034.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-053034 | | 2025-03-14 | 18:57 ET | [8-K](/filings/0000950170-25-039317.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-25-039317 | | 2025-02-25 | 21:37 ET | [10-K](/filings/0000950170-25-026773.md) | Annual report, period 2024-12-31 | 0000950170-25-026773 | | 2025-02-25 | 21:13 ET | [8-K](/filings/0000950170-25-026668.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-026668 | | 2025-01-13 | 15:30 ET | [8-K](/filings/0000950170-25-004633.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-004633 | | 2024-11-12 | 21:14 ET | [10-Q](/filings/0000950170-24-125409.md) | Quarterly report, period 2024-09-30 | 0000950170-24-125409 | | 2024-11-12 | 21:08 ET | [8-K](/filings/0000950170-24-125371.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-125371 | | 2024-10-22 | 20:20 ET | [SC 13D](/filings/0001193125-24-241076.md) | Ownership report, active investor | 0001193125-24-241076 | | 2024-10-15 | 21:28 ET | [8-K](/filings/0000950170-24-114767.md) | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-114767 | | 2024-10-09 | 11:38 ET | [S-1/A](/filings/0000950170-24-113629.md) | Registration statement, amended | 0000950170-24-113629 | | 2024-10-07 | 10:19 ET | [S-1/A](/filings/0000950170-24-113073.md) | Registration statement, amended | 0000950170-24-113073 | | 2024-09-19 | 20:32 ET | [S-1/A](/filings/0000950170-24-108128.md) | Registration statement, amended | 0000950170-24-108128 | | 2024-08-26 | 20:43 ET | [S-1](/filings/0000950170-24-100574.md) | Registration statement | 0000950170-24-100574 | Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:06 ET. No prices; not investment advice.